This invention discloses a recombinant human (or bovine)
basic fibroblast growth factor gel with wound-healing and antibacterial functions, and its preparation method. Recombinant human (or bovine)
basic fibroblast growth factor gel is a
genetically engineered topical drug used clinically to promote healing of burn wounds, chronic wounds, and fresh wounds, with significant
efficacy. However, its drawbacks include limited antibacterial properties and inability to be used simultaneously with chemical disinfectants such as
iodine and
ethanol, which, while promoting
wound healing, are not conducive to controlling
wound infection. Research has found that
protamine sulfate or
polylysine, with high safety and good antibacterial properties, can exert good antibacterial and anti-infection functions without negatively affecting the bioactivity and stability of recombinant human (or bovine)
basic fibroblast growth factor. This represents an advanced method for preparing recombinant human (or bovine) basic
fibroblast growth factor gel with wound-healing and antibacterial functions, enabling this type of
drug to better exert its clinical effects and expand its application scope.